Ozempic Prescription in Sherman, Texas at DFWPMA

Looking for an Ozempic prescription in Sherman, Texas? Ozempic (semaglutide) is a prescription GLP-1 medication that requires comprehensive medical assessment because improper use or inadequate supervision can cause serious health complications.

At DFW Physicians Medical Associates (DFWPMA), our endocrinology, internal medicine, and primary care providers evaluate diabetes, metabolic conditions, medication history, and potential treatment risks to establish whether Ozempic is medically appropriate.

DFWPMA provides Ozempic prescription evaluations in Sherman and can prescribe Ozempic to eligible patients when clinically indicated. Ozempic is primarily used for adults with type 2 diabetes and certain related cardiovascular or kidney risks, while other semaglutide formulations are approved specifically for chronic weight management.

Book an appointment online or call (903) 957-0082 to contact our Sherman location.
Address: 📍
425 N Highland Ave., Suite 260, Sherman, TX 75092

Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for an Ozempic Prescription in Sherman, Texas?

DFW Physicians Medical Associates offers Ozempic prescription evaluations in Sherman through medical professionals experienced in endocrinology, diabetes management, internal medicine, and primary care. Our multispecialty services support comprehensive eligibility assessments, personalized medical recommendations, and continued monitoring when Ozempic is an appropriate treatment option.

Patients seeking an Ozempic prescription at DFWPMA Sherman can benefit from:

  • Experienced Medical Providers: Access to endocrinology, internal medicine, and primary care professionals experienced in diabetes and chronic disease management.
  • Comprehensive Eligibility Assessment: Reviewing medical history, diabetes diagnosis, current medications, and contraindications before considering treatment.
  • Diabetes and Metabolic Health Evaluation: Assessing hemoglobin A1c, blood glucose, weight-related conditions, and relevant metabolic health indicators.
  • Individualized Prescription Decisions: Selecting appropriate treatment according to approved indications, clinical findings, potential risks, and patient needs.
  • Medication Safety Screening: Identifying relevant concerns involving pancreatitis, gastrointestinal disorders, gallbladder conditions, medullary thyroid carcinoma, and multiple endocrine neoplasia syndrome type 2 (MEN2).
  • Dosage Management and Monitoring: Providing appropriate dose adjustments and evaluating medication tolerance, adverse effects, and clinical progress.
  • Long-Term Diabetes Management: Monitoring blood sugar control, cardiovascular health, kidney-related concerns, and associated chronic diseases.
  • Coordinated Multispecialty Care: Connecting patients with additional medical services when complex diabetes or metabolic conditions require specialized evaluation.

Ozempic should only be prescribed following an appropriate medical assessment. A patient requesting a GLP-1 medication must first be evaluated for treatment indications, expected benefits, contraindications, adverse effect risks, and suitable alternatives.

DFWPMA Sherman emphasizes responsible prescribing, patient-specific treatment planning, and regular follow-up rather than providing prescriptions without adequate clinical evaluation.

Schedule an appointment with DFWPMA Sherman to review your Ozempic prescription eligibility and treatment options.

Meet Our Ozempic Prescription Providers in Sherman, Texas

DFWPMA Sherman offers Ozempic prescription evaluations through providers with expertise in endocrinology, diabetes care, internal medicine, family medicine, and chronic disease management. Our medical team can evaluate treatment eligibility and prescribe Ozempic when clinically appropriate.

Gitana Staskus, MD – Endocrinology

Dr. Gitana Staskus is a board-certified endocrinologist with more than 20 years of experience diagnosing and managing endocrine and metabolic conditions in adults and older adults.

Her clinical expertise includes type 1 and type 2 diabetes, gestational diabetes, weight management, thyroid disorders, hormonal conditions, osteoporosis, and complex metabolic diseases. Dr. Staskus emphasizes patient education, individualized medical recommendations, and long-term endocrine care.

Her specialized experience in diabetes and metabolic disorders is particularly relevant to Ozempic prescription assessments, including patients with type 2 diabetes and additional metabolic health concerns.

Aniwelyn Tan, DNP – Primary Care

Aniwelyn Tan is an experienced family nurse practitioner and primary care provider with more than 20 years of healthcare experience, including extensive experience caring for patients with chronic medical conditions.

Her areas of expertise include diabetes, obesity, weight management, high blood pressure, internal medicine, and chronic disease treatment. She also has substantial cardiovascular nursing experience and provides primary care for patients ages 15 and older.

Her experience managing diabetes, obesity, and related medical conditions supports Ozempic prescription evaluations, including assessment of metabolic health, medication safety, and continued monitoring of treatment outcomes.

Ayodya Perera, MD – Family Medicine

Dr. Ayodya Perera is a family medicine physician providing comprehensive primary care, preventive healthcare, and chronic disease management for adolescents and adults ages 15 and older.

Dr. Perera’s clinical interests include diabetes management, weight management, hypertension, preventive medicine, and individualized treatment planning. The physician emphasizes shared decision-making and helping patients understand their available medical options.

This background in diabetes and weight-related healthcare is relevant to Ozempic prescription evaluations, including reviewing chronic conditions, assessing treatment eligibility, and developing individualized medical care plans.

Book an appointment online to inquire about Ozempic prescription evaluations with DFWPMA’s medical providers in Sherman.

What Can an Ozempic Prescription in Sherman, Texas Help With?

Ozempic (semaglutide) is a weekly injectable GLP-1 medication used to improve blood glucose control in adults with type 2 diabetes. It also helps reduce certain cardiovascular and kidney risks in eligible patients. Weight loss can occur during treatment, but Ozempic is not specifically approved for chronic weight management.

At DFWPMA Sherman, Ozempic prescription evaluations address:

  • Type 2 Diabetes Management: Supporting improved blood sugar regulation in adults with type 2 diabetes.
  • Elevated Hemoglobin A1c: Helping reduce glucose levels that exceed personalized diabetes treatment goals.
  • Cardiovascular Risk Reduction: Reducing major cardiovascular events in eligible patients with type 2 diabetes.
  • Diabetic Kidney Disease: Lowering certain kidney and cardiovascular risks in qualifying adults.
  • Weight Changes Associated With Treatment: Potentially reducing appetite and supporting weight loss as secondary treatment effects.
  • Complex Diabetes Treatment Needs: Assessing Ozempic when existing diabetes treatment requires modification.
  • Diabetes With Additional Metabolic Conditions: Addressing type 2 diabetes alongside obesity, high blood pressure, or elevated cholesterol.

Ozempic improves glycemic regulation by stimulating glucose-dependent insulin release, suppressing glucagon secretion, and slowing gastric emptying. The American Academy of Family Physicians identifies GLP-1 medications as established pharmacologic options for type 2 diabetes.

Source: American Academy of Family Physicians – Management of Type 2 Diabetes Mellitus With Noninsulin Pharmacotherapy

Ozempic is not indicated for type 1 diabetes and must not be used by patients with a personal or family history of medullary thyroid carcinoma or MEN2. Important safety considerations include pancreatitis, gastrointestinal complications, dehydration, and gallbladder disease.

Patients interested primarily in semaglutide for weight reduction should discuss medications approved specifically for chronic weight management, such as Wegovy.

Source: American College of Physicians – Pharmacologic Treatments for Overweight and Obesity

Schedule an appointment to discuss Ozempic prescription eligibility at DFWPMA Sherman.

What Ozempic Prescription Services Are Available at DFWPMA Sherman?

DFWPMA Sherman provides Ozempic prescription evaluations, diabetes and metabolic assessments, medication safety screening, individualized treatment recommendations, and ongoing medical monitoring through endocrinology, internal medicine, and primary care providers.

Our Ozempic prescription services include:

  • Initial Ozempic Prescription Evaluation: Reviewing medical history, diabetes diagnosis, and eligibility for treatment.
  • Diabetes and Metabolic Testing: Assessing hemoglobin A1c, blood glucose, kidney function, and metabolic health markers.
  • Medication and Contraindication Review: Evaluating current prescriptions, contraindications, and potential medication-related complications.
  • Ozempic Prescription and Treatment Planning: Prescribing Ozempic when appropriate and establishing individualized treatment goals.
  • Starting Dose and Titration: Adjusting medication doses based on prescribing recommendations and patient tolerance.
  • Side Effect Monitoring: Assessing nausea, gastrointestinal symptoms, dehydration, and other adverse effects.
  • Blood Sugar and Treatment Response Monitoring: Measuring glycemic control and evaluating medication effectiveness.
  • Long-Term Diabetes and Metabolic Care: Managing diabetes and associated cardiovascular or metabolic health concerns.
  • Alternative GLP-1 Medication Evaluation: Exploring other medications when Ozempic is not medically suitable.
  • Follow-Up and Coordinated Care: Providing continued monitoring and specialty referrals when needed.

Ozempic treatment commonly starts with 0.25 mg once weekly for four weeks before increasing to 0.5 mg weekly. Additional dosage changes depend on treatment effectiveness and tolerability.

Common side effects include nausea, diarrhea, vomiting, and constipation. Severe abdominal pain, significant dehydration, or serious allergic reactions require prompt medical evaluation.

The American College of Physicians emphasizes selecting medications according to individual treatment benefits, clinical risks, affordability, and long-term health objectives.

Source: American College of Physicians – Clinical Guidance on Pharmacologic Weight Management

Not every patient is eligible for Ozempic. A medical assessment helps establish whether this medication or another diabetes treatment is appropriate.

More GLP-1 Prescriptions Available in Sherman

Related Ozempic Content

Looking for an Ozempic prescription in Sherman, Texas? Book an appointment or call (903) 957-0082 to schedule your evaluation at DFWPMA.